Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Shared structural features of the 9aaTAD family in complex with CBP

M. Piskacek, A. Vasku, R. Hajek, A. Knight,

. 2015 ; 11 (3) : 844-551. [pub] 20150107

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT14310 MZ0 CEP Register

A number of transactivation domains for transcription factors including p53, E2A/HEB, MLL, cMyb, CREB, FOXO3, Gcn4, Oaf1 and Pdr1 have been reported to interact with the KIX domain of general transcriptional mediators CBP, p300 or MED15. Most of those factors belong to the already established Nine amino acid Transactivation Domain (9aaTAD) family. By using available structural data, we found binding analogy for the 9aaTAD in the MLL-KIX and also E2A/HEB-KIX complexes. We recognized two distinct TAD formations in the KIX complex. In the E2A/HEB-KIX complex, the leucine position is determined by the prolonged helical structure including the 9aaTAD and the leucine (long-helical TAD). However in the MLL-KIX complex, the equal position of 9aaTAD and proximal leucine is achieved differently by leucine-turn-helix structural architecture. Furthermore, the FOXO3-KIX complex shares structural analogy with the E2A-KIX complex in respect of both 9aaTAD and proximal leucine. Next, from (i) sequence alignment of the identified 9aaTADs in p53, E2A/HEB and MLL proteins and (ii) the resolved structure of the MLL-KIX and E2A/HEB-KIX complexes, we generated a plausible structural model for p53 that could be used also for other members of the 9aaTAD family. The position of 9aaTADs in Oaf1-, Pdr1- and Gcn4-MED15 KIX complexes and 9aaTAD composition are in good agreement with E2A, MLL, FOXO3 and p53. Analyses of structural data in this study define fundamental structural requirements and shed more light on the ambiguous 9aaTAD domain.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000405
003      
CZ-PrNML
005      
20191021101819.0
007      
ta
008      
160108s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1039/c4mb00672k $2 doi
035    __
$a (PubMed)25564305
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Piskáček, Martin $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Czech Republic. Piskacek@med.muni.cz. $7 xx0213400
245    10
$a Shared structural features of the 9aaTAD family in complex with CBP / $c M. Piskacek, A. Vasku, R. Hajek, A. Knight,
520    9_
$a A number of transactivation domains for transcription factors including p53, E2A/HEB, MLL, cMyb, CREB, FOXO3, Gcn4, Oaf1 and Pdr1 have been reported to interact with the KIX domain of general transcriptional mediators CBP, p300 or MED15. Most of those factors belong to the already established Nine amino acid Transactivation Domain (9aaTAD) family. By using available structural data, we found binding analogy for the 9aaTAD in the MLL-KIX and also E2A/HEB-KIX complexes. We recognized two distinct TAD formations in the KIX complex. In the E2A/HEB-KIX complex, the leucine position is determined by the prolonged helical structure including the 9aaTAD and the leucine (long-helical TAD). However in the MLL-KIX complex, the equal position of 9aaTAD and proximal leucine is achieved differently by leucine-turn-helix structural architecture. Furthermore, the FOXO3-KIX complex shares structural analogy with the E2A-KIX complex in respect of both 9aaTAD and proximal leucine. Next, from (i) sequence alignment of the identified 9aaTADs in p53, E2A/HEB and MLL proteins and (ii) the resolved structure of the MLL-KIX and E2A/HEB-KIX complexes, we generated a plausible structural model for p53 that could be used also for other members of the 9aaTAD family. The position of 9aaTADs in Oaf1-, Pdr1- and Gcn4-MED15 KIX complexes and 9aaTAD composition are in good agreement with E2A, MLL, FOXO3 and p53. Analyses of structural data in this study define fundamental structural requirements and shed more light on the ambiguous 9aaTAD domain.
650    _2
$a aminokyselinové motivy $7 D020816
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a vazebná místa $7 D001665
650    _2
$a protein vázající CREB $x chemie $x metabolismus $7 D050882
650    _2
$a databáze proteinů $7 D030562
650    _2
$a forkhead transkripční faktory $x chemie $x metabolismus $7 D051858
650    12
$a molekulární modely $7 D008958
650    12
$a molekulární konformace $7 D008968
650    _2
$a protoonkogenní protein MLL $x chemie $7 D051788
650    _2
$a vazba proteinů $7 D011485
650    12
$a interakční proteinové domény a motivy $7 D054730
650    _2
$a transkripční faktory $x chemie $x metabolismus $7 D014157
650    _2
$a nádorový supresorový protein p53 $x chemie $x metabolismus $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vašků, Anna, $d 1954- $7 mzk2006356130
700    1_
$a Hajek, Roman
700    1_
$a Knight, Andrea
773    0_
$w MED00169253 $t Molecular bioSystems $x 1742-2051 $g Roč. 11, č. 3 (2015), s. 844-551
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25564305 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20191021102252 $b ABA008
999    __
$a ok $b bmc $g 1102686 $s 924611
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 11 $c 3 $d 844-551 $e 20150107 $i 1742-2051 $m Molecular bioSystems $n Mol Biosyst $x MED00169253
GRA    __
$a NT14310 $p MZ0
LZP    __
$a Pubmed-20160108

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...